Mertens, Nathalie
Schmidt, Mark E.
Hijzen, Anja
Van Weehaeghe, Donatienne
Ravenstijn, Paulien
Depre, Marleen
de Hoon, Jan
Van Laere, Koen
Koole, Michel
Funding for this research was provided by:
Fund for Scientific Research, Belgium
Article History
Received: 6 March 2021
Accepted: 29 July 2021
First Online: 9 August 2021
Competing interests
: Data was available as part of a phase 1 PET study, sponsored by Janssen Pharmaceutics (principal investigator Koen Van Laere). Nathalie Mertens is PhD mandate holder of the Fund for Scientific Research, Flanders, Belgium (FWO). Mark E. Schmidt, Anja Hijzen and Paulien Ravenstijn are employees of Janssen Research & Development (Beerse, Belgium). No other potential conflict of interest relevant to this article was reported. All other authors do not have conflict of interest.